# NRX Pharmaceuticals, Inc.: Form DEF 14A, filed Sep 5, 2024

- Company: [NRX Pharmaceuticals, Inc.](/companies/nrxp.md) (CIK 1719406)
- Form: DEF 14A
- Filed: 2024-09-05
- Accepted by EDGAR: Sep 5, 2024, 16:18 ET
- Period: 2024-10-08
- Accession: 0001437749-24-028549
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1719406/000143774924028549/nrxp20240904_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719406/000143774924028549/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719406/000143774924028549/nrxp20240904_def14a.htm

Filed Sep 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-028549. Last ingested by Listed: Nov 5, 2026, 19:01 ET. No prices; not investment advice.